Core Viewpoint - Zhejiang Huahai Pharmaceutical Co., Ltd. announced a significant decrease in its 2025 annual net profit, projecting a range of 224 million to 335 million yuan, which represents a decline of approximately 70% to 80% compared to the previous year [4][7]. Group 1: Financial Performance - The company expects its net profit attributable to shareholders for 2025 to be between 224 million and 335 million yuan, a decrease of approximately 78.4 million to 89.5 million yuan from the previous year [4][7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 113 million and 226 million yuan, reflecting a decline of about 90.3 million to 101.6 million yuan year-on-year [4][7]. - The previous year's net profit was reported at 1.119 billion yuan, with a per-share earnings of 0.77 yuan [8]. Group 2: Reasons for Performance Change - The decline in profit is attributed to intensified competition and price pressure in the domestic formulation business, leading to a decrease in sales revenue [8]. - The raw material pharmaceutical industry is facing overcapacity and price pressures, with new product development not meeting expectations, further impacting sales revenue [8]. - Increased investment in the research and development of innovative biological drugs has also contributed to the rise in expenses [8]. Group 3: Convertible Bond Price Adjustment - The company’s board decided not to adjust the conversion price of the "Huahai Convertible Bonds" downwards, despite the stock price falling below 80% of the conversion price for at least 15 trading days within a 30-day period [14][24]. - The current conversion price is set at 33.06 yuan per share, with the initial conversion price being 34.66 yuan per share [15][24]. - The board will reassess the situation after March 27, 2026, should the conditions for a downward adjustment be met again [14][24].

Core Viewpoint - The board of directors of Great Wall Motors has decided not to lower the conversion price of the "Changqi Convertible Bond" despite triggering the conditions for a downward adjustment due to stock price performance [2][5][18]. Group 1: Meeting Decisions - The board held its 46th meeting on January 23, 2026, with all 8 directors present, and unanimously approved the proposal not to adjust the conversion price of the "Changqi Convertible Bond" [1][2]. - The decision was made based on confidence in the company's long-term potential and to protect the interests of all investors [18]. Group 2: Convertible Bond Details - The "Changqi Convertible Bond" was issued on June 10, 2021, with a total amount of 3.5 million bonds, each with a face value of 100 yuan, totaling 3.5 billion yuan [6][7]. - The bond has a maturity period of 6 years, from June 10, 2021, to June 9, 2027, with an initial conversion price of 38.39 yuan per share, which has been adjusted multiple times since issuance [7][19]. - The current conversion price is 39.61 yuan per share, and the bond's conversion period is from December 17, 2021, to June 9, 2027 [7][19]. Group 3: Price Adjustment Conditions - The conditions for a downward adjustment of the conversion price were triggered when the company's A-share stock price was below 85% of the current conversion price for at least 15 out of 30 consecutive trading days [5][17]. - The board has decided not to propose a downward adjustment for the next 6 months, from January 24, 2026, to July 23, 2026, even if the conditions are met again during this period [18].

Core Viewpoint - The company has announced a downward adjustment of the conversion price for its convertible bonds, "Fangyuan Convertible Bonds," from 18.63 yuan per share to 14.00 yuan per share, effective January 23, 2026, due to the stock price falling below the threshold for adjustment [10][11][16]. Meeting Details - The first extraordinary general meeting of shareholders was held on January 21, 2026, at the company's conference room in Jiangmen, Guangdong [2]. - The meeting was attended by all nine current directors and the board secretary, with voting conducted through a combination of on-site and online methods [3][4]. Voting Results - The proposal to adjust the conversion price was passed with more than two-thirds of the voting rights held by attending shareholders [5][6]. - Shareholders holding "Fangyuan Convertible Bonds" were required to abstain from voting on this matter [7]. Legal Compliance - The meeting was witnessed by Beijing Guofeng Law Firm, which confirmed that the procedures followed were in compliance with relevant laws and regulations [8]. Conversion Price Adjustment - The conversion price was adjusted downward due to the company's stock price being below 85% of the previous conversion price for at least 15 trading days within a 30-day period [13][14]. - The previous conversion price was adjusted from 18.62 yuan to 18.63 yuan on October 30, 2023, following the termination of a stock incentive plan [12]. Market Impact - The average trading price of the company's stock over the 20 trading days prior to the meeting was 9.40 yuan per share, which influenced the decision to set the new conversion price at 14.00 yuan [16].

Core Viewpoint - The company has decided not to exercise the downward adjustment of the conversion price for the "Weir Convertible Bonds" despite triggering the conditions for such an adjustment as of January 15, 2026 [2][9]. Group 1: Convertible Bond Overview - The company issued 2,440 million yuan worth of convertible bonds, known as "Weir Convertible Bonds," with an initial conversion price of 222.83 yuan per share [3]. - The bonds have a maturity period from December 28, 2020, to December 27, 2026, with a conversion period from July 5, 2021, to December 27, 2026 [3]. Group 2: Conversion Price Adjustment History - The conversion price was adjusted from 222.83 yuan to 222.52 yuan after a cash dividend distribution of 3.15 yuan per 10 shares in 2020 [4]. - Following a cash dividend of 0.52 yuan per share and a capital increase of 0.35 shares per share in 2021, the conversion price was further adjusted to 164.44 yuan [4]. - The conversion price was adjusted to 164.36 yuan after a cash dividend of 0.84 yuan per 10 shares in 2022 [4]. - The conversion price was adjusted to 162.80 yuan following the issuance of 31 million GDRs at a price of 14.35 USD each [5]. - After a cash dividend of 1.40 yuan per 10 shares in 2023, the conversion price was adjusted to 162.66 yuan [6]. - The conversion price was adjusted to 162.46 yuan after a cash dividend of 2.00 yuan per 10 shares in the mid-2024 profit distribution [6]. - Following a cash dividend of 2.20 yuan per 10 shares in 2024, the conversion price was adjusted to 162.24 yuan [6]. - The conversion price was adjusted to 161.84 yuan after a cash dividend of 4.00 yuan per 10 shares in the mid-2025 profit distribution [6]. - The conversion price was adjusted to 159.38 yuan after the issuance of 45.8 million H shares on January 12, 2026 [7]. Group 3: Downward Adjustment Conditions - The company triggered the downward adjustment clause for the conversion price as the stock price fell below 85% of the current conversion price for 15 out of 30 consecutive trading days [8]. - The board of directors voted unanimously to not exercise the downward adjustment right and will not propose any adjustment for the next six months [9].

Group 1 - The core point of the news is that Bluestar Medical (002382) is proposing to lower the conversion price of its convertible bonds due to the stock price being below the required threshold for a certain period [1][2][4] - On January 8, 2026, Bluestar Medical's stock closed at 5.86 yuan, with a 1.21% increase, a turnover rate of 1.43%, a trading volume of 142,500 shares, and a transaction amount of 83.22 million yuan [1] - The company reported a net outflow of 285.43 million yuan from institutional investors and a net inflow of 432.3 million yuan from retail investors on January 8 [1][4] Group 2 - The Board of Directors of Bluestar Medical approved a proposal to lower the conversion price of the "Bluestar Convertible Bonds" due to the stock price being below 85% of the conversion price for at least 15 out of the last 30 trading days [1][2] - The proposed adjustment to the conversion price will be submitted for approval at the first extraordinary general meeting of shareholders in 2026, scheduled for January 26, 2026 [2] - The adjustment must be approved by more than two-thirds of the voting rights held by shareholders present at the meeting, and bondholders must abstain from voting [2]

Group 1 - The company held its 37th meeting of the sixth board of directors on January 7, 2026, via electronic communication, with all 8 directors participating [2][5] - The board proposed to lower the conversion price of the "Blue Sail Convertible Bond" due to the stock price being below 85% of the conversion price for at least 15 out of the last 30 trading days, triggering the condition for price adjustment [3][31][46] - The proposed adjustment will be submitted to the shareholders' meeting for approval, and the new conversion price must not be lower than the higher of the average stock price over the last 20 trading days before the meeting and the last trading day's price, as well as not lower than the latest audited net asset value per share and the par value [3][46] Group 2 - The company decided to hold its first extraordinary shareholders' meeting of 2026 on January 26, 2026, to discuss the proposed adjustment of the convertible bond conversion price [6][7] - The meeting will be conducted both in-person and via online voting, with specific time slots for voting provided [13][19] - Shareholders holding the convertible bonds must abstain from voting on the proposal to adjust the conversion price, which requires a two-thirds majority approval from the attending shareholders [15][46]

Group 1 - The company held its 37th meeting of the sixth board of directors on January 7, 2026, via electronic communication, with all 8 directors participating [2][3]. - The board proposed to lower the conversion price of the "Blue Sail Convertible Bond" due to the stock price being below 85% of the current conversion price for at least 15 out of the last 30 trading days [3][12][28]. - The proposed adjustment to the conversion price requires approval from the shareholders' meeting, and the new price must not be lower than the higher of the average stock price over the last 20 trading days before the meeting or the latest audited net asset value per share [3][28]. Group 2 - The company plans to hold its first extraordinary shareholders' meeting of 2026 on January 26, 2026, to discuss the proposed adjustment to the bond conversion price [6][7][32]. - The meeting will be conducted both in-person and via online voting, with specific time slots for voting outlined [34][45]. - Shareholders holding the convertible bonds must abstain from voting on the proposal to adjust the conversion price [40].

Group 1 - The company held its 25th meeting of the 8th Board of Directors on December 26, 2025, with all 8 directors present, complying with relevant laws and regulations [2][3] - The Board unanimously approved the proposal not to adjust the conversion price of the Yunda convertible bonds, despite the stock price triggering the downward adjustment condition [3][7][14] - The stock price was below 85% of the current conversion price for at least 15 trading days within a 30-day period, triggering the condition for downward adjustment [7][12][14] Group 2 - The Yunda convertible bonds were issued on April 11, 2023, with a total amount of RMB 245 million, and are set to mature in 2029 [8][9] - The initial conversion price was set at RMB 12.15 per share, which has been adjusted to RMB 11.73 per share due to annual equity distribution plans [11] - The company will not propose any downward adjustment for the conversion price in the next six months, even if the adjustment conditions are triggered again [14]

Group 1 - The company held its 31st meeting of the 6th Board of Directors on December 19, 2025, with all 5 directors present, meeting the legal quorum requirements [2] - The Board unanimously approved the proposal not to lower the conversion price of the "Honglu Convertible Bonds" [3] - The current conversion price is set at RMB 32.08 per share, and the conversion period is from April 15, 2021, to October 8, 2026 [7][9] Group 2 - The company has triggered the downward adjustment clause for the conversion price, as the stock price has been below 85% of the conversion price for 15 trading days within a 30-day period [12][14] - The Board decided against lowering the conversion price, citing confidence in the company's long-term development and intrinsic value [14] - If the downward adjustment clause is triggered again after December 22, 2025, the Board will convene to decide on the adjustment [14]

Core Viewpoint - The company has triggered the downward adjustment clause for its convertible bonds due to the stock price being below 85% of the conversion price for 15 trading days [1] Group 1 - The company's stock price has been below 85% of the current conversion price from November 28, 2025, to December 18, 2025 [1] - The company will hold the 14th meeting of the 6th Board of Directors on December 18, 2025, to review the proposal for the downward adjustment of the conversion price of the convertible bonds [1] - The proposal for the adjustment will be submitted for approval at the company's shareholders' meeting [1]